Hormonal treatment options include: Combined oral contraceptives : Continuous or cyclic regimens can reduce menstrual flow and suppress endometrial tissue activity Progestins : Available as oral medications, injections (depot medroxyprogesterone acetate), intrauterine devices (levonorgestrel-releasing IUD), or implants GnRH agonists : These medications induce a temporary menopausal state, effectively suppressing endometriosis but requiring add-back hormone therapy to minimize bone loss and vasomotor symptoms [21] [20] GnRH antagonists : FDA-approved oral options include elagolix (Orilissa) and relugolix/estradiol/norethindrone (Myfembree) with specific duration limits based on dosing and bone health considerations [18] [19] Aromatase inhibitors : Sometimes used in refractory cases, though not FDA-approved for this indication [23] [24] Bone mineral density monitoring is recommended for patients on long-term GnRH agonists or antagonists, particularly at higher doses or extended durations

GLP-1 Agonist IS TO BE ADMINISTERED ONCE PER WEEK
No changes have been made to the meals themselves
[7] Patches are typically worn once daily for 68 hours, though some are marketed for overnight use
Medical Supervision and Genetic Testing at PlexusDx PlexusDx operates under direct clinical oversight to ensure your GLP-1 therapy is safe and effective
Conclusion Skin reactions associated with GLP-1 medications extend beyond simple injection-site irritation